Table 1.
FFirst author | Disease | Setting | Sessions | Session length (h:mm) | Delivery | Deliverer | N | Inhaler type | Maximum follow-up (months) | Outcome type | Inhaler technique Improvement | Clinical outcomes | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(%) | (p.p.) | ||||||||||||
Al-Showair 200715 | Asthma | Outpatient clinic | 1 | – | Individual | – | 107 | MDI | 1.5 | IFR | – | Peak flow:↑, AQLQ: ↑ | |
Armour 201316 | Asthma | Pharmacy | 4 | 00:26 | Individual | Pharmacist | 398 | MDI | 6 | Patients | 50 p.p. | ACQ:≈ | |
Basheti 200817 | Asthma | Pharmacy | 4 | 00:03 | Individual | Pharmacist | 97 | DPI | 6 | Steps | 49% | Asthma severity: ↓ | |
Basheti 200518 | Asthma | Pharmacy | 1 | 00:08 | Individual | Researcher | 17 | DPI | 0.5 | Steps | 75% | None | |
Asthma | Pharmacy | 1 | 00:08 | Individual | Researcher | 17 | DPI | 0.5 | Steps | 80% | |||
Bosnic-Anticevich 201019 | Both | Pharmacy | 3 | – | Individual | Researcher | 52 | MDI | 4 | Steps | 38% | None | |
Bynum 200120 | Asthma* | Outpatient clinic | 1 | 00:15 | Individual | Pharmacist | 49 | MDI | 1 | Steps | 77% | None | |
Carpenter 201521 | Asthma* | Outpatient clinic | 1 | 00:03 | Individual | Researcher | 91 | MDI | 1 | Steps | 16% | ACT: ≈ | |
Chan 200722 | Asthma* | Outpatient clinic | 5 | – | Individual | Other | 60 | MDI | 12 | Steps | 8% | QOL: ≈, hospitalisations: ≈ | |
Asthma* | Outpatient clinic | 5 | – | Individual | Other | 60 | DPI | 12 | Steps | 12% | |||
Chan 200323 | Asthma* | Outpatient clinic | 4 | – | Individual | Other | 10 | Both | 6 | Steps | – | Peak flow: ↑, QOL: ≈ | |
Cicutto 201324 | Asthma* | School | 6 | 00:53 | Group | – | 1316 | – | 12 | Steps | 48% | QOL:↑, Urgent care:↓ | |
Cordina 200125 | Asthma | Pharmacy | 1 | – | Individual | – | 152 | – | 12 | Patients | 36 p.p. | QOL: ↑, peak flow: ↑, hospitalisations: ↓ | |
Crane 201426 | Asthma | – | 1 | – | Individual | – | 123 | Both | 12 | Patients | 16 p.p. | None | |
De Blaquiere 198927 | Both | Outpatient clinic | 1 | 00:17 | Individual | Researcher | 100 | MDI | 2 | Patients | 81 p.p. | Hospitalisations: ≈ | |
De Oliveira 199928 | Asthma | Outpatient clinic | 8 | – | – | Researcher | 42 | MDI | 6 | Patients | 73 p.p. | ER visits:↓, symptoms:↓, QOL:↑ | |
Garcia-Cardenas 201329 | Asthma | Pharmacy | 3 | – | Individual | Pharmacist | 336 | DPI | 6 | Patients | 56 p.p. | ACQ:↑ | |
Goodyer 200630 | Asthma | – | 1 | – | Individual | Pharmacist | 35 | MDI | 0 | Steps | – | None | |
Asthma | – | 1 | – | Individual | Pharmacist | 34 | MDI | 0 | Steps | – | |||
Goris 201331 | COPD | Outpatient clinic | 1 | – | Individual | – | 24 | MDI | 3 | Steps | 100% | QOL:↑, attacks:↓, hospitalisations:≈ | |
COPD | Outpatient clinic | 1 | – | Individual | – | 110 | DPI | 3 | Steps | 43% | |||
Hesselink 200432 | Both | Other | 2 | 00:30 | Individual | Nurse | 276 | – | 24 | Patients | – | QOL: ≈ | |
Horner 200833 | Asthma* | School | 16 | 00:15 | Group | Other | 183 | MDI | 1.5 | Steps | 36% | None | |
Kiser 201234 | COPD | Hospital | 1 | 00:23 | Individual | Researcher | 99 | MDI | 1.25 | Steps | 29% | None | |
COPD | Hospital | 1 | 00:23 | Individual | Researcher | 41 | DPI | 1.25 | Steps | 22% | |||
COPD | Hospital | 1 | 00:23 | Individual | Researcher | 27 | DPI | 1.25 | Steps | 20% | |||
Kools 200635 | Asthma | – | 1 | 00:01 | Individual | Researcher | 50 | MDI | 0 | Steps | – | None | |
Kritikos 200736 | Asthma | Pharmacy | 1 | 02:30 | Group | Pharmacist | 22 | MDI | 3 | Patients | 73 p.p. | Poor control: ↓, AQOL: ↑ | |
Asthma | Pharmacy | 1 | 02:30 | Group | Pharmacist | 25 | DPI | 3 | Patients | 79 p.p. | |||
Asthma | Pharmacy | 1 | 02:30 | Group | Researcher | 20 | MDI | 3 | Patients | 86 p.p. | |||
Asthma | Pharmacy | 1 | 02:30 | Group | Researcher | 26 | DPI | 3 | Patients | 84 p.p. | |||
Kumar 200937 | Both | Hospital | 4 | – | Individual | Pharmacist | 98 | MDI | 2 | Steps | 115% | FEV1:↑ | |
Both | Hospital | 4 | – | Individual | Pharmacist | 18 | DPI | 2 | Steps | 100% | |||
Martin 201538 | Asthma* | Other | 4 | – | Individual | Nurse | 51 | – | 12 | Steps | 50% | Control: ≈ | |
Asthma* | Other | 4 | – | Individual | Nurse | 50 | – | 12 | Steps | 29% | |||
Mehuys 200839 | Asthma | Pharmacy | 3 | – | Individual | Pharmacist | 201 | Both | 6 | Steps | 25% | Nighttime symptoms:↓, ACT:↑ | |
Mulloy 199640 | Asthma | Outpatient clinic | 1 | – | Individual | Nurse | 60 | – | 12 | Steps | 20% | Symptoms: ↓, peak flow: ≈ | |
Patterson 200541 | Asthma* | School | 8 | – | Group | Nurse | 173 | – | 4 | Patients | 38 p.p. | QOL: ≈ | |
Perneger 200242 | Asthma | Hospital | 3 | 01:15 | Group | Other | 131 | – | 6 | Patients | 28 p.p. | QOL: ≈, healthcare utilisation: ≈ | |
Petkova 200843 | Asthma | Pharmacy | 5 | – | – | Researcher | 50 | – | 4 | Patients | 14 p.p. | Hospitalisation: ↓, QOL:↑ | |
Press 201244 | Both | Hospital | 1 | 00:06 | Individual | Researcher | 50 | MDI | 0 | Patients | 52 p.p. | Health-related events:↓ | |
Both | Hospital | 1 | 00:06 | Individual | Researcher | 18 | DPI | 0 | Patients | 50 p.p. | |||
Rahmati 201445 | Asthma | – | 3 | – | Group | – | 60 | MDI | 1 | Steps | 60% | Peak flow: ↑ | |
Asthma | – | 3 | – | Group | – | 60 | MDI | 1 | Steps | 90% | |||
Rootmensen 200846 | Both | Outpatient clinic | 1 | 00:45 | Individual | Nurse | 191 | – | 6 | Steps | 3% | QOL: ≈, Exacerbations: ↓ | |
Rydman 199947 | Asthma | Outpatient clinic | 1 | – | Individual | Researcher | 68 | MDI | 3 | Patients | 36 p.p. | None | |
Santos 201048 | Asthma | Outpatient clinic | 2 | 01:00 | Individual | Pharmacist | 28 | MDI | 2 | Steps | 167% | None | |
Asthma | Outpatient clinic | 2 | 01:00 | Individual | Pharmacist | 28 | DPI | 2 | Steps | 33% | |||
Tommelein 201449 | COPD | Pharmacy | 2 | 00:20 | Individual | Pharmacist | 734 | Both | 3 | Steps | 38% | Hospitalisations↓ | |
Toumas-Shehata 201450 | Asthma | Pharmacy | 1 | – | Individual | Pharmacist | 101 | DPI | 1 | Steps | 40% | ACQ:↑ | |
Van der Palen 199751 | COPD | Outpatient clinic | 1 | 00:45 | Group | Nurse | 70 | Both | 9 | Steps | 26% | None | |
COPD | Outpatient clinic | 1 | 00:45 | Individual | Other | 73 | Both | 9 | Steps | 18% | |||
COPD | Other | 1 | 00:45 | Individual | Other | 71 | Both | 9 | Steps | 26% | |||
Verver 199652 | Asthma | Other | 1 | – | Individual | Nurse | 48 | DPI | 0.5 | Steps | 9% | Dyspnoea: ↓ | |
Wilson 199353 | Asthma | Hospital | 4 | 00:45 | Individual | Nurse | 227 | MDI | 12 | Steps | – | Asthma status: ↑, physical activity: ↑, Acute visits:↓ | |
Asthma | Hospital | 4 | 01:30 | Group | Nurse | 229 | MDI | 12 | Steps | – |
*: children, ↑: increase/improvement, ↓: decrease/worsening, ≈: no difference, Outcome type: mean number or percentage of correct steps (in the table: “Steps”), the percentage of patients who showed a correct technique (in the table: “Patients”), or inhalation flow rate (IFR). Improvement over baseline is either reported as percentage (%) or as percentage points (p.p.)